The data suggest that the mutated ARH1 proteins may also be unable to hydrolyze in vivo ADP-ribosylated protein found in the tumor, thus resulting in cancers, despite the presence of ARH1 enzymatic activity. The gene discussed is LDLRAP1; the disease is neoplasm.